Factors Influencing Volumetric MR-HIFU Ablation of Uterine Fibroids

Status Completed

Clinical Trial Summary

Magnetic resonance (MR)-guided high-intensity focused ultrasound (HIFU) ablation is increasingly being used worldwide to treat symptomatic uterine fibroids because of its excellent therapeutic efficacy in controlling symptoms and its excellent safety record. Despite the benefits, it should be recognized that MR HIFU ablation does not always yield good therapeutic outcomes. High signal intensity on T2-weighted MR images and a high volume transfer constant (or Ktrans) on dynamic contrast material-enhanced MR images are the most well-known risk factors for poor ablation outcomes as measured with the non-perfused volume (NPV) ratio (ie, NPV divided by fibroid volume).

The aim of this study is to assess the influence of fibroid perfusion (evaluated by MRI and contrast enhanced ultrasound), apparent diffusion coefficient (evaluated by MR-diffusion imaging) and fibroid stiffness (evaluated by ARFI) on ablation efficiency during uterine fibroid treatment by MR-HIFU.

Clinical Trial Description

Preprocedural predictors of treatment efficacy will be useful for excluding in advance patients who would not benefit from this treatment, thereby contributing to improved overall clinical outcomes. During ablathermy treatment lost of energy depend of tissue perfusion and thermic diffusion while energy laying depend of tissue absorption coefficient. Study these parameters before treatment could bring important information to the treatment difficulty and its efficacy. The investigators will study and compare fibroid perfusion with dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound (CEUS). CEUS will be performed with contrast agent (SONOVUE). Thermic diffusion could be linked with fibroid stiffness. Fibroid stiffness will be quantified with velocity of shear wave measured by acoustic radiation force impulse (ARFI). Tissue absorption coefficient is correlated with the architecture and the cellularity of the tissue so the investigators think that apparent diffusion coefficient (computed with diffusion weighted imaging) could be correlated with ablathermy efficiency and other intra procedural thermal parameters. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02386137
Study type	Interventional
Source	University Hospital, Bordeaux
Contact
Status	Completed
Phase	N/A
Start date	July 22, 2015
Completion date	October 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04073485` - Microwave Ablation for Uterine Fibroids	N/A
Recruiting	`NCT04519593` - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma	N/A
Recruiting	`NCT01239641` - High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids	Phase 4
Recruiting	`NCT04748978` - OPPIuM Technique and Myolysis With Diode Laser Dwls	N/A
Not yet recruiting	`NCT04191603` - TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY	N/A
Terminated	`NCT04132349` - Ulipristal Acetate in Symptomatic Uterine Fibroid	Phase 4
Completed	`NCT03412890` - LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids	Phase 3
Completed	`NCT03021720` - Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial	N/A
Recruiting	`NCT04209036` - Can 3D Laparoscopy Improve Surgical Performances in Surgeons in Training?
Completed	`NCT05086770` - Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere	N/A
Recruiting	`NCT05416424` - Life Study: Lifestyle Intervention in Fibroid Elimination	N/A
Not yet recruiting	`NCT05695690` - Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification
Enrolling by invitation	`NCT06430320` - Ascertaining Longterm Outcomes of Fibroid Treatments
Completed	`NCT04832906` - UA Versus UAE in Treatment of Fibroids	Phase 4
Completed	`NCT03444987` - The Role of Fibroblast Activation in Uterine Fibroid
Active, not recruiting	`NCT06244251` - Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids	N/A
Not yet recruiting	`NCT06153667` - Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
Not yet recruiting	`NCT03450421` - Safety and Efficacy of Actamax™Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy	N/A
Not yet recruiting	`NCT05840042` - Epidemiology and Risk Factors of Uterine Fibroids in China
Completed	`NCT04345003` - MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Factors Influencing Volumetric MR-HIFU Ablation of Uterine Fibroids — PERAGUS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms